OBI Pharma USA Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
OBI Pharma USA, Inc. is a biotechnology research firm based in San Diego, California, and operates as the wholly owned U.S. subsidiary of OBI Pharma, Inc. Its primary remit is to lead the United States and European clinical trials for OBI’s novel therapeutic agents addressing unmet medical needs. The subsidiary functions with a small team focused on supporting development activities and coordination with the parent company. Within the biotechnology sector, OBI Pharma USA positions itself as a clinical development partner to advance OBI’s pipeline through trials in major markets. Its target customers include research institutions, potential collaborators, and industry partners involved in clinical testing and development of new therapeutics. A notable development from the parent company is the launch of GlycOBIR, a glycan site-specific conjugation technology, announced at the 5th World ADC Summit in South Korea in 2026.